Benjamin Arthur

Mr. Benjamin Arthur

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2025 in Cells
Verified
Journal Article
Open access
PDF file
JGJustin Gibson
Justin Gibson
ADAbishek Dhungana
Abishek Dhungana
MPMenam Pokhrel
Menam Pokhrel
BABenjamin Arthur
Benjamin Arthur
PSPramita Suresh
Pramita Suresh
RCRenee Cottle
Renee Cottle
Hepatocyte transplantation (HTx) combined with ex vivo gene therapy has garnered significant interest due to its potential for treating many inherited metabolic liver diseases. The biggest obstacle for HTx is achieving sufficient engraftment levels to rescue diseased phenotypes, which becomes more challenging when combined with ex vivo gene editing techniques. However, recent technological advancements have improved electroporation delivery efficiency, cell viability, and scalability for cell therapy. We recently demonstrated the impacts of electroporation for cell-based gene therapy in a mouse model of hereditary tyrosinemia type 1 (HT1). Here, we explore the use of the clinical-grade electroporator, the MaxCyte ExPERT GTx, utilized in the first FDA-approved CRISPR therapy, Casgevy, and evaluate its potential in primary hepatocytes in terms of delivery efficiency and cell viability. We assessed the gene editing efficiency and post-transplantation engraftment of hepatocytes from mTmG mice electroporated with CRISPR-Cas9-ribonucleoproteins (RNPs) targeting 4-hydroxyphenylpyruvate dioxygenase (Hpd) in a fumarylacetoacetate hydrolase (Fah)-deficient mouse model of HT1. After surgery, Fah-/- graft recipients were cycled off and on nitisinone to achieve independence from drug-induced Hpd inhibition, an indicator of HT1 disease correction. Transplanted hepatocytes subjected to electroporation using the GTx system had a cell viability of 89.9% and 100% on-target gene editing efficiency. Recipients transplanted with GTx-electroporated cells showed a smaller weight reduction than controls transplanted with untransfected cells (7.9% and 13.8%, respectively). Further, there were no mortalities in the GTx-recipient mice, whereas there was 25% mortality in the control recipients. Mean donor cell engraftment was significantly higher in GTx-recipient mice compared to untransfected control recipients (97.9% and 81.6%, respectively). Our results indicate that the GTx system does not negatively impact hepatocyte functionality and engraftment potential, thereby demonstrating the promise of GTx electroporation in hepatocytes as a viable cell therapy for treating genetic diseases that affect the liver.

20 August 2025 in Biology
Verified
Journal Article
Open access
CCCallie Clark
Callie Clark
MPMenam Pokhrel
Menam Pokhrel
BABenjamin Arthur
Benjamin Arthur
PSPramita Suresh
Pramita Suresh
IAIlayda Ates
Ilayda Ates
RCRenee Cottle
Renee Cottle
We previously demonstrated lipid nanoparticle-mediated CRISPR-Cas9 gene editing to disrupt the gene encoding cytochrome P450 oxidoreductase (Cypor), combined with transient administration of acetaminophen (APAP), to repopulate the liver with healthy hepatocytes and rescue a phenylketonuria mouse model. This study aimed to investigate electroporation-mediated delivery of Cypor-targeting CRISPR-Cas9 ribonucleoproteins into wild-type hepatocytes, combined with liver engraftment under APAP treatment, as an in vivo selection approach in a mouse model of homozygous familial hypercholesterolemia (Ldlr−/−). Electroporation provides higher delivery efficiency compared to lipid nanoparticles. We observed engraftment levels up to 13% engraftment of electroporated Cypor-deficient hepatocytes with indels in the liver of Ldlr−/− mice after transient APAP administration, while negligible engraftment was observed in no-APAP controls (mean 9% and 2%, respectively, p = 0.0121). The engraftment of Cypor-deficient Ldlr+/+ hepatocytes was associated with reductions in LDL-cholesterol (18%) and triglycerides (52%) compared to the untransplanted control Ldlr−/− mice fed a Western diet for 5 weeks, but offered no protection from the development of diet-induced aortic root atherosclerosis or liver steatosis. While biochemical markers for liver damage normalized after discontinuation of APAP, we observed persistent lipid accumulation in the liver of Ldlr−/− mice grafted with Cypor-deficient Ldlr+/+ hepatocytes, likely stemming from the impact of Cypor deficiency on cholesterol clearance. Therefore, the combination of CRISPR-Cas9-mediated Cypor knockdown to induce clonal expansion of gene-edited hepatocytes using transient APAP administration is not a viable therapeutic strategy for familial hypercholesterolemia due to the essential role of Cypor in cholesterol metabolism. Unlike findings from phenylketonuria mouse model studies, the loss of Cypor function could not be compensated by unedited native hepatocytes in Ldlr−/− mice. Collectively, our results demonstrate that electroporation is a viable and informative approach for evaluating gene editing strategies for the treatment of inherited metabolic diseases that affect the liver. Our electroporation procedure revealed that a one-size-fits-all gene editing strategy may not be universally applicable for treating inherited metabolic liver disorders. Tailored gene editing and selection strategies may be needed for different liver disorders.

29 July 2024 in Journal of Science and Technology (Ghana)
Verified
Journal Article
Closed access
PDF file
FEFiifi Amoako Atta Panyin Essiam
Fiifi Amoako Atta Panyin Essiam
MAMary Amoako Adjepong
Mary Amoako Adjepong
DADesmond Afoakwa
Desmond Afoakwa
ABAkosua Konadu Boateng
Akosua Konadu Boateng
BABenjamin Arthur
Benjamin Arthur
Collins Afriyie AppiahCollins Afriyie Appiah
Collins Afriyie Appiah
Purpose: Diabetes is a serious global public health issue with increasing prevalence over the years especially in developing countries. This study assessed the relationship between food security, dietary intake, physical activity levels and blood glucose levels of adults in a peri-urban community in Ghana. Methodology: In this cross-sectional study, 94 participants were recruited and quantitative data were collected using a structured questionnaire. Socio-demographics, anthropometry, fasting blood glucose (FBG), dietary intake, physical activity and food security data were collected. Findings: Of the 94 eligible respondents aged 18 years and above, 37.2% were men while 62.8% were women. The mean age, BMI and FBG levels were 33.3 years, 26.8 kg/m2 and 6.4 mmol/L respectively. About 27.7% of the participants were food insecure. Average calorie intake was 3244.20 kcal and this had a significant association with blood glucose status (p <0.001). Prevalence of impaired fasting glucose was 71.3% (range: FBG = 5.7 - 6.9 mmol/L) and 19.1% (range: FBG ≥ 7mmol/L) in the prediabetes and diabetes range respectively. About 52.1% of the population were physically active with males being more physically active (54.3%) than females (50.8%). Total energy intake (p < 0.001) and BMI levels (p = 0.009) were significantly associated with the FBG levels. There was however no significant relationship between physical activity, food security and FBG. Conclusion: Stakeholders should design plans to encourage a balanced diet, enough physical exercise, and a healthy weight in the municipality in order to curb the prevalence of prediabetes and type 2 diabetes in the study population.